Accretive Health Reports Inducement Grant

Accretive Health, Inc. (OTC Pink: ACHI) today announced that pursuant to the offer letter agreement entered into with Emad Rizk, M.D., on July 10, 2014, the company granted to Dr. Rizk on July 21, 2014 a nonstatutory stock option and shares of restricted common stock (collectively the “Inducement Grants”) as an inducement material to Dr. Rizk’s acceptance of employment with the company. The Inducement Grants were approved by the company’s Board of Directors on July 9, 2014. The company previously announced that Dr. Rizk has been appointed President, Chief Executive Officer, and a member of the company's Board of Directors, effective July 21, 2014.

The stock option is for the purchase of 2,700,000 shares of the company’s common stock, with an exercise price of $8.98, which was the closing price of the company’s common stock reported through the facilities of the OTC Markets Group Inc. on July 21, 2014. The restricted stock award was a grant of 1,000,000 shares of restricted common stock of the company. The stock option generally will vest in equal annual installments over four years following the grant date, subject to continued service with the company. One-half of the restricted stock award generally will vest in equal annual installments over four years following the grant date, subject to continued service with the company. The remaining one-half of the restricted stock award generally will vest based on a stock price performance goal of two times the closing price of a share of the company’s common stock on the grant date, which must be equaled or exceeded for at least twenty (20) consecutive trading days based on the average closing price for such twenty (20)-consecutive trading day period. The Inducement Grants will be issued outside of the company’s 2010 Stock Incentive Plan.

About Accretive Health

At Accretive Health, our mission is to partner with healthcare communities to serve as a catalyst for a healthier future for all. For more information, visit www.accretivehealth.com.